COMPATIBILITY STUDY BETWEEN ACETYLCYSTEINE AND SOME COMMONLY USED TABLET EXCIPIENTS

被引:9
作者
KERC, J
SRCIC, S
URLEB, U
KANALEC, A
KOFLER, B
SMIDKORBAR, J
机构
[1] EDVARD KARDELJ UNIV, DEPT PHARM, YU-61000 LJUBLJANA, SLOVENIA
[2] LEK PHARMACEUT & CHEM WORKS, DEPT RES & DEV, LJUBLJANA, SLOVENIA
关键词
D O I
10.1111/j.2042-7158.1992.tb03657.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Differential scanning calorimetry (DSC), Fourier transform infra-red spectroscopy (FT-IR), HPLC and TLC were use to investigate the interactions between the mucolytic drug acetylcysteine and a number of commonly used tablet and capsule excipients. Acetylcysteine was found to be compatible with microcrystalline cellulose (Avicel PH 101), sodium carboxymethylcellulose, amorphous silicon dioxide (Aerosil), PVP, cross-linked PVP (Polyplasdone XL), corn starch, saccharose and magnesium stearate. Acetylcysteine thermal stability (onset degradation temperature) was decreased in mixtures with corn starch, magnesium stearate, saccharose and lactose. Interactions of acetylcysteine with lactose, PEG 4000 and 6000, glycine, adipic acid and saccharin sodium were found using DSC and studied in detail with FT-IR, HPLC and TLC. The results suggest that acetylcysteine in mixtures with PEG 4000, glycine or saccharin sodium is degraded during storage at conditions of high temperature and humidity.
引用
收藏
页码:515 / 518
页数:4
相关论文
共 8 条
[1]   INTERACTION OF DEXTROAMPHETAMINE SULFATE WITH SPRAY-DRIED LACTOSE [J].
BLAUG, SM ;
HUANG, WT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (11) :1770-&
[2]   COMPARISON OF REACTIVITY OF AMPHETAMINE METHAMPHETAMINE AND DIMETHYLAMPHETAMINE WITH LACTOSE AND RELATED COMPOUNDS [J].
DUVALL, RN ;
KOSHY, KT ;
PYLES, JW .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1965, 54 (04) :607-&
[3]   SOLID-STATE REACTIONS - THEORETICAL AND EXPERIMENTAL ASPECTS [J].
MONKHOUSE, DC ;
VANCAMPEN, L .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1984, 10 (8-9) :1175-1276
[4]  
PO ALW, 1984, INT J PHARM, V18, P287
[5]   DESIGN FOR DRUG-EXCIPIENT INTERACTION STUDIES [J].
VANDOOREN, AA .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1983, 9 (1-2) :43-55
[6]  
WELLS JI, 1988, PHARM PREFORMULATION, P215
[7]  
1990, US PHARMACOPEIAL C, P272
[8]  
SAVEZNI ZAVOD ZDRAVS, P21